NCT04959851View on ClinicalTrials.gov

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

CompletedOBSERVATIONAL
Enrollment

185

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

June 18, 2024

Study Completion Date

June 18, 2024

Conditions
Inflammatory Bowel DiseasesColitis, UlcerativeCrohns Disease
Trial Locations (10)

400

CHC MontLégia, Liège

1070

Erasme, Brussels

2018

GZA St. Vincentius, Antwerp

2650

UZA, Antwerp

3600

ZOL, Genk

4000

CHR Citadelle, Liège

CHU Liège, Liège

7500

CHWAPI, Tournai

8800

AZ Delta, Roeselaere

9000

AZ St. Lucas, Ghent

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY